Change in mammographic density (MD) with metformin use: Alliance A211201, A companion study to NCIC study MA.32
Conferences
Wood, M; Elsaid, MJ; Grimm, LJ; Liu, H; Oswold, C; Kuzma, CS; Bedrosian, I; Ligibel, J; Goodwin, PJ
Published in: CLINICAL CANCER RESEARCH
February 17, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
CLINICAL CANCER RESEARCH
EISSN
1557-3265
ISSN
1078-0432
Publication Date
February 17, 2026
Volume
32
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wood, M., Elsaid, M. J., Grimm, L. J., Liu, H., Oswold, C., Kuzma, C. S., … Goodwin, P. J. (2026). Change in mammographic density (MD) with metformin use: Alliance A211201, A companion study to NCIC study MA.32. In CLINICAL CANCER RESEARCH (Vol. 32).
Wood, M., M. J. Elsaid, L. J. Grimm, H. Liu, C. Oswold, C. S. Kuzma, I. Bedrosian, J. Ligibel, and P. J. Goodwin. “Change in mammographic density (MD) with metformin use: Alliance A211201, A companion study to NCIC study MA.32.” In CLINICAL CANCER RESEARCH, Vol. 32, 2026.
Wood M, Elsaid MJ, Grimm LJ, Liu H, Oswold C, Kuzma CS, et al. Change in mammographic density (MD) with metformin use: Alliance A211201, A companion study to NCIC study MA.32. In: CLINICAL CANCER RESEARCH. 2026.
Wood, M., et al. “Change in mammographic density (MD) with metformin use: Alliance A211201, A companion study to NCIC study MA.32.” CLINICAL CANCER RESEARCH, vol. 32, 2026.
Wood M, Elsaid MJ, Grimm LJ, Liu H, Oswold C, Kuzma CS, Bedrosian I, Ligibel J, Goodwin PJ. Change in mammographic density (MD) with metformin use: Alliance A211201, A companion study to NCIC study MA.32. CLINICAL CANCER RESEARCH. 2026.
Published In
CLINICAL CANCER RESEARCH
EISSN
1557-3265
ISSN
1078-0432
Publication Date
February 17, 2026
Volume
32
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences